Stock listing
Olema Pharmaceuticals, Inc.
Selected listing: OLMA · NASDAQ · USD · US
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA), Health Technology. Latest release Oct 2, 2026: Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule…
- Ticker
- NASDAQ:OLMA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. is a public company traded under the ticker OLMA in the American market. Olema focuses on developing innovative therapies for women's cancers, aiming to address unmet medical needs in this area.
Latest news from Olema Pharmaceuticals, Inc.
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2026
Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer
August 13, 2026
Olema Oncology Reports Second Quarter 2026 Financial and Operating Results
August 10, 2026
Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer
May 26, 2026
Research Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. company profile
View the public company page for Olema Pharmaceuticals, Inc. on 6ix.
Olema Pharmaceuticals, Inc. news
Read company news and market updates connected to Olema Pharmaceuticals, Inc..
Olema Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Olema Pharmaceuticals, Inc..